ArticleScientific reports2025
Determination of optimum extract conditions and evaluation of biological activity potential of Salvia cilicica Boiss.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Biological activity of Pleurotus eryngii based on antioxidant, anticholinesterase and antiproliferative effects using optimized extraction methods.Scientific reports · 2026Article
- Artificial Intelligence-Assisted Optimization ofFoods (Basel, Switzerland) · 2026Article
- Comprehensive Characterization of Polyphenols from Salvia chudaei: HPLC-PDA Profiling, in vitro Biological Activities, and in silico Enzyme Interactions.The protein journal · 2026Article
- Evaluation of phenolic profile and multi-biological activities of Lepista glaucocana extracts optimized by ANN-GA and RSM models.Scientific reports · 2026Article
- Evaluation of the phenolic profile and biological activities of Boletus speciosus extracts optimized with response surface methodology and artificial neural networks-genetic algorithm.Scientific reports · 2026Article
- Optimizing Ultrasonic-Assisted Extraction Process ofMolecules (Basel, Switzerland) · 2025Article
- Geographical variation in antioxidant, anticancer and anticholinesterase activities and phenolic contents of Visnaga daucoides.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants are important natural resources used for many purposes. They especially stand out with their medical potential. In this study, the extract conditions showing the highest biological activity were optimized using the artificial intelligence application of Salvia cilicica Boiss. Then, the biological activities of the optimized extract were determined. Response Surface Method was used for optimization. Using the Box-Behnken experimental design, antioxidant capacities of the optimized extracts were evaluated through Rel Assay TAS and TOS kits, as well as DPPH and FRAP methods. Anticholinesterase activity was assessed by measuring acetyl- and butyrylcholinesterase enzyme activities. Total phenolic content was quantified using the Folin-Ciocalteu reagent, while total flavonoid content was analyzed via the aluminum chloride assay. The antiproliferative potential was examined against the A549 lung cancer cell line, and phenolic compounds were identified using an LC-MS/MS system. Optimization results indicated that the ideal extraction parameters were 45.890 °C, 7.730 h, and a 96.431 ethanol-to-water ratio. The extract obtained under these conditions exhibited a TAS value of 7.461 ± 0.065 mmol/L, a TOS value of 5.630 ± 0.163 µmol/L, and an OSI value of 0.075 ± 0.002. Total phenolic and flavonoid contents were measured as 97.681 ± 1.076 mg/g and 113.067 ± 0.621 mg/g, respectively. The FRAP value reached 70.669 ± 0.199 mg/g, while the DPPH value was determined as 53.208 ± 0.427 mg/g. Furthermore, anti-AChE and anti-BChE activities were recorded at 12.93 ± 0.72 µg/mL and 25.87 ± 1.44 µg/mL, respectively. The extract demonstrated notable cytotoxicity against the A549 cancer cell line. Additionally, 10 distinct phenolic compounds were identified in the plant. These findings highlight the significant biological potential of S. cilicica extract obtained under optimal conditions, suggesting its potential as a valuable natural resource in pharmacological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.